The pharmaceutical care services importance in the education and health diabetic patients recovery: an integrative review
DOI:
https://doi.org/10.33448/rsd-v10i13.21149Keywords:
Diabetes mellitus; Basic care; Pharmaceutical; Hyperglycemia.Abstract
Introduction: A Diabetes Mellitus (DM) is a metabolic disorder characterized by persistent hyperglycemia. It is currently a global epidemic, affecting more than 424 million individuals worldwide. Thus, the structuring of a pharmaceutical follow-up service contributes to better adherence to treatment and reduction of injuries arising from the lack of control of the pathology. Objective: To identify, through an integrative literature review, the impact of interventions performed by the pharmacist within the primary health care service on the control of clinical parameters of type II diabetes mellitus. Method: The construction of the database was carried out by the BVS Regional Portal. Experimental and non-experimental studies, published between 2015 and 2019, were included. After applying the descriptors, the total number of eligible articles found was 188 full texts, then the texts are proofreaders as appropriate to the research topic. Results: In all, eleven articles met the inclusion criteria, being them randomized, cohort studies and systematic reviews. The listed articles sought to measure the impact of interventions performed by the pharmacist, their applicability and outcome in the clinical improvement of diabetic patients. For this, laboratory tests, checking blood pressure and the presence of correlated diseases, which influence the primary clinical condition of the individual, are analyzed. Conclusion: The pharmaceutical follow-up and the interventions performed favor the control of clinical and laboratory parameters, reducing the risk of secondary complications and uncontrolled DM and related diseases.
References
BRASIL (2015). Desenvolvimento da versão brasileira resumida do Diabetes Quality of Life Measure (DQOL-Brasil-8). Rev. bras. epidemiol., São Paulo , v. 18, n. 4, p. 943-952, Dez. 2015 .
BRASIL (2013). Resolução Nº 585 de 29 de agosto de 2013. Dispões sobre a regulamenta as atribuições clínicas do farmacêutico e dá outras providências. Conselho Federal de Farmácia, agosto/2013.
BRASIL (2014). Ministério da Saúde. Serviços farmacêuticos na atenção básica à saúde / Ministério da Saúde, Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Assistência Farmacêutica e Insumos Estratégicos. – Brasília : Ministério da Saúde, 2014. 108 p. : il. – (Cuidado farmacêutico na atenção básica ; caderno 1).
CHEN, J.; OU, H. e LIN, T. et al. (2016). Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial. Int J Clin Pharm 38, 88-95 (2016).
GUDLAUGSDOTTIR, HL; SIGURDARDOTTIR, AK (2018). Diabetes is a challenge: A ten year follow up of people with diabetes. Laeknabladid , v. 104, n. 4, p. 171-176, 2018.
IQBAL, M.Z.; KHAN, A.H.; IQBAL, M.S.; SYED SULAIMAN, S.A (2019). A Review of Pharmacist-led Interventions on Diabetes Outcomes: An Observational Analysis to Explore Diabetes Care Opportunities for Pharmacists.. J. Pharm Bioallied Sci . 2019; 11 (4): 299‐309.
JEONG, S.; LEE, M.; JI, E. (2018). Effect of pharmaceutical care interventions on glycemic control in patients with diabetes: a systematic review and meta-analysis, Ther Clin Risk Manag. 2018; 14: 1813-1829.
KORCEGEZ, E. I.; SANCAR, M.; DEMIRKAN, K. (2017). Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial. J Manag Care Spec Pharm, v. 23, n. 5, p. 573-582, 2017.
LIM, P. C. et al. (2016) Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia. Pak J Pharm Sci, v. 29, n. 2 de 2016.
LOPES, G.V.D.O.; VILASBÔAS, A.L.Q.; CASTELLANOS, M.E.P. (2017). Atenção Domiciliar na Estratégia Saúde da Família: avaliação do grau de implantação em Camaçari (BA). Saúde em Debate, v. 41, p. 241-254, 2017.
LYONS, I; BARBER, N.; RAYNOR, D.K. et al. (2016). The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence. BMJ Quality & Safety 2016. Oct;25(10):759-69.
MINISTÉRIO DA SAÚDE (2017). Agência Saúde: Obesidade. 17 de Abril de 2017. Disponível em <http://portalms.saude.gov.br/noticias/agencia-saude/28108-em-dez-anos-obesidade-cresce-60-no-brasil-e-colabora-para-maior-prevalencia-de-hipertensao-e-diabetes>.
PEREIRA, L. B et al. (2018). Avaliação da efetividade do acompanhamento farmacoterapêutico no controle do diabetes mellitus tipo 2 em longo prazo. Clinical & Biomedical Research, v. 38, n. 3, 2018.
RAMIRES, E.K.N.M. et al (2018). Prevalência e Fatores Associados com a Síndrome Metabólica na População Adulta Brasileira: Pesquisa Nacional de Saúde–2013. Arq Bras Cardiol, v. 110, n. 5, p. 455-466, 2018.
SHARP, L. K. et al. (2018). Community health workers supporting clinical pharmacists in diabetes management: a randomized controlled trial. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, v. 38, n. 1, p. 58-68, 2018.
SIAW, M. Y. L. et al. (2017). Impact of pharmacist‐involved collaborative care on the clinical, humanistic and cost outcomes of high‐risk patients with type 2 diabetes (IMPACT): a randomized controlled trial. Journal of clinical pharmacy and therapeutics, v. 42, n. 4, p. 475-482, 2017.
Sociedade Brasileira de Diabetes (2017). Conduta terapêutica no diabetes tipo 2: algoritmo SBD – Posicionamento Oficial SBD no 02/2017. São Paulo.
Sociedade Brasileira de Diabetes (2020). Conduta terapêutica no diabetes tipo 2: algoritmo SBD – Diretrizes da sociedade brasileira do diabete 2019/2020. São Paulo.
VAN EIKENHORST, L.; TAXIS, K.; VAN DIJK, L.; DE GIER, H. (2017). Pharmacist-Led Self-management Interventions to Improve Diabetes Outcomes. A Systematic Literature Review and Meta-Analysis. Front Pharmacol. 2017 Dec 14;8:891.
VIGITEL (2018): Vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico / Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde. – Brasília: Ministério da Saúde, 2018.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Ana Júlia Santos; Marcos Valério Santos da Silva; Marcieni Ataíde Andrade
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
